Metlife Europe

🏢 MetLife EU Holding Company Limited is an Irish-incorporated intermediate holding company, 100% owned by MetLife Global Holding Company II GmbH (Germany) and ultimately controlled by MetLife, Inc. (NYSE: MET). The holding company consolidates two Irish-authorised operating subsidiaries — MetLife Europe d.a.c. (life insurance) and MetLife Europe Insurance d.a.c. (non-life insurance) — under the Solvency II group reporting framework supervised by the Central Bank of Ireland. MetLife Europe d.a.c. operates through branches in eleven countries and via Freedom of Services in Germany and Austria, leveraging the EU single market's passporting regime from a single Irish regulatory base.

📊 Financial performance. MetLife Europe d.a.c. generated €1,270 million in premium and fee income for FY 2024 (Irish GAAP), up 9.1% year-on-year, while EMEA segment adjusted earnings reached $283 million (US GAAP), up 12% on a constant-currency basis. The group solvency ratio fell from 208% (FY 2022) to 172% (FY 2024), driven primarily by €376 million in upstream dividends over 2023–2024 and the Part VII transfer of €246 million in net assets to MetLife UK Limited, a newly created entity outside the group perimeter.

📈 Strategic positioning. Under MetLife Inc.'s New Frontier strategy unveiled in December 2024, Europe is positioned as a dependable cash-generating platform rather than a primary growth engine, with international growth ambitions directed toward Latin America and Asia. All four major rating agencies maintain stable ratings on MetLife Inc., with insurance financial strength ratings at AA−/Aa3/AA− (S&P/Moody's/Fitch) and A+ (Superior) from AM Best, unchanged throughout 2020–2025.

~*~

Corporate structure and the Irish passporting model

🏛️ Holding architecture. MetLife EU Holding Company Limited sits beneath MetLife Global Holding Company II GmbH (Germany) in the MetLife, Inc. corporate chain. It consolidates two Irish-authorised operating subsidiaries under Solvency II group supervision by the Central Bank of Ireland. MetLife Europe d.a.c. is the principal life insurance entity, authorised for Classes I, III, IV, and VI of life assurance and Classes 1 and 2 of non-life, operating through branches in the UK, Italy, Spain, Portugal, France, Czech Republic, Bulgaria, Slovakia, Hungary, Romania, and Cyprus, with Freedom of Services in Germany and Austria. MetLife Europe Insurance d.a.c. is a smaller non-life entity writing involuntary loss of employment, mobile phone insurance, travel, and credit and suretyship coverage through branches in seven countries and FOS in Germany, Austria, Greece, and Poland. The holding company itself employs no staff directly; all personnel are engaged through MetLife Europe Services Limited and MetLife Services EEIG.

🌍 Passporting model. The structure leverages the EU single market's passporting regime from a single Irish regulatory base. Ireland's insurance sector writes business into over 110 countries serving more than 25 million customers, and MetLife is one of several major international groups exploiting this model.

🇵🇱 Poland and Greece divestitures. Two transformative structural events reshaped the group perimeter during the review period. MetLife sold its Polish and Greek life insurance, pension, and asset management operations to NN Group N.V. for a combined consideration of €584 million. The Greek completion occurred on 31 January 2022, with Poland completing on 22 April 2022 following KNF approval. A residual Polish direct-to-consumer book in MetLife Europe Insurance d.a.c. was transferred to NN via FOS on 1 April 2023, and a final withheld payment of €13 million was received in July 2023.

🇬🇧 UK Part VII transfer. The second transformative event was the UK Part VII transfer, completed on 1 April 2024, which moved the closed onshore UK wealth management portfolio (unit-linked investment bonds and retirement products) from MetLife Europe d.a.c. to MetLife UK Limited (MUKL), a newly PRA-authorised entity. MUKL sits outside the MetLife EU Holding Company perimeter — it is a direct subsidiary of MetLife Inc. via MGHC II — meaning €246 million in net assets exited the group's Solvency II scope.

~*~

Financial performance

💰 Three accounting frameworks. MetLife's European operations are reported under three distinct accounting frameworks. US GAAP governs MetLife Inc.'s EMEA segment disclosure in SEC filings. Irish GAAP (FRS 102/FRS 103) is the statutory reporting basis for the Irish entities, having replaced IFRS effective 1 January 2023, creating a comparability break in the statutory accounts. Solvency II provides the regulatory capital and balance sheet perspective.

📊 MetLife Inc. — EMEA segment adjusted earnings (USD mm), FY 2020–FY 2024

Metric	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
Adj earnings	~327	~301	249	265	283
Adj PFOs	—	—	2,281	2,346	2,548
Change (reported, YoY)	—	—	—	+6%	+7%
Change (CC)	—	—	—	—	+12%

📉 Divestiture impact on comparability. The FY 2020 and FY 2021 figures include subsequently divested businesses (Russia, Greece, Poland) that contributed materially to the segment. On a like-for-like basis excluding divestitures, the underlying EMEA earnings trajectory from FY 2022 to FY 2024 shows consistent mid-to-high single-digit growth. In Q4 2024, EMEA adjusted earnings reached $59 million (up 31% constant currency), with sales surging 28% on a constant-currency basis — the strongest quarterly performance in the review period. EMEA represents approximately 4.9% of MetLife Inc.'s total adjusted earnings ($5,796 million in FY 2024) and a similar share of group adjusted PFOs ($52,379 million).

📊 MetLife Europe d.a.c. — Underwriting performance (EUR mm), FY 2020–FY 2024, Irish GAAP/IFRS

Metric	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
Premium & fee income	—	1,115	1,154	1,164	1,270
Net earned premium	—	908	990	1,009	1,167
Claims incurred	—	(487)	(462)	(537)	(588)
Operating expenses	—	—	(183)	(197)	(205)
Underwriting result	—	256	315	307	316
Profit for the year	—	128	168	120	137

🌱 Growth drivers. The 9.1% premium growth in FY 2024 is notable given the UK wealth management portfolio was transferred out on 1 April 2024. Growth was driven by the retained protection and employee benefits business, particularly in Central Europe (Czech Republic, Romania, Slovakia) where premium and fee income rose from €339 million to €368 million, and in the UK and Ireland segment, which grew from €301 million to €373 million as active employee benefits expanded. By line of business, other life insurance (€715 million) and health insurance (€349 million) together account for 84% of premium and fee income, with index-linked/unit-linked business contributing €102 million and non-life insurance providing €74 million.

🔧 Non-life subsidiary. MetLife Europe Insurance d.a.c. is substantially smaller, generating €11,014 thousand in net earned premium (FY 2024), down from €13,184 thousand in FY 2023, primarily because the Polish DTC health insurance business (€2,117 thousand in FY 2023) was transferred to NN Group on 1 April 2023. The entity returned to profitability in FY 2024 with a €1,065 thousand profit (versus a €131 thousand loss in FY 2023), driven by the absence of the Poland disposal loss and growing credit and suretyship business. The implied net claims ratio is 9.4%, reflecting the low-frequency, low-severity nature of the ILOE and mobile phone insurance books. The entity paid a €4.8 million dividend to MetLife EU Holding in December 2024.

~*~

Solvency position

⚠️ Material tightening since 2022. The group solvency ratio declined by 36 percentage points over two years, from 208% (FY 2022) to 172% (FY 2024). Own funds decreased by €121 million (from €1,316 million to €1,195 million) while the SCR increased by €60 million (from €634 million to €694 million).

📊 MetLife EU Holding Company Limited — Group solvency ratio time series (Solvency II, EUR mm), FY 2020–FY 2024

Metric	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
Group solvency ratio	195%	—	208%	201%	172%
Eligible own funds (SCR)	1,814	—	1,316	1,304	1,195
Tier 1	—	—	1,290	1,293	1,172
Tier 3 (net DTA)	—	—	26	11	23
Group SCR	933	—	634	648	694
Group MCR	—	—	281	286	307

📊 MetLife Europe d.a.c. — Solo solvency ratio (Solvency II, EUR mm), FY 2020–FY 2024

Metric	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
Solvency ratio	186%	196%	198%	190%	161%
Eligible own funds	—	1,382	1,218	1,196	1,085
SCR	—	704	616	629	673

📊 MetLife Europe Insurance d.a.c. — Solo solvency ratio (Solvency II, EUR thousands), FY 2023–FY 2024

Metric	FY 2023	FY 2024
Solvency ratio	310%	264%
Eligible own funds	44,369	42,938
SCR	14,309	16,275

💸 Own funds erosion. Dividend payments are the dominant factor. MetLife EU Holding Company paid €178 million to its German parent in 2023 and €198 million in 2024, funded by upstream dividends from MetLife Europe d.a.c. (€160 million and €193 million respectively) and MetLife Europe Insurance d.a.c. (€2 million and €5 million). Over the two-year period, cumulative upstream dividends of approximately €376 million dwarfed organic capital generation (retained profits of approximately €164 million per year at the group level, before dividends). The UK Part VII transfer removed €246 million of net assets from the group perimeter, though this was partially an intragroup reallocation. Operating profits, favourable claims experience in the UK and Italy, and positive lapse experience in Romania provided partial offsets.

📐 SCR increase. Life underwriting risk SCR rose from €457 million to €503 million, driven by growth in employee benefits business (UK Group Life, Romania, Slovakia) and disability/morbidity modelling refinements for UK Group Income Protection. Counterparty default risk SCR jumped from €55 million to €73 million, reflecting changes in reinsurance counterparty exposure following the Part VII transfer. The loss-absorbing capacity of deferred taxes decreased from €79 million to €64 million, increasing the net SCR.

✅ Assessment. At 172%, the group solvency ratio remains well above the 100% regulatory minimum and above MetLife's internal risk appetite thresholds. ORSA assessments for both 2023 and 2024 concluded the group is adequately capitalised. The trajectory indicates a deliberate capital efficiency strategy by MetLife Inc., extracting surplus from European operations at a pace exceeding organic generation. Expected profits included in future premiums (EPIFP) of €1,059 million at the group level provide a large embedded value buffer, representing nearly 89% of total eligible own funds.

~*~

Bermuda reinsurance and funds-withheld architecture

🔄 MRB quota share. MetLife Europe d.a.c.'s most significant counterparty concentration historically resided in its affiliated reinsurance relationship with MetLife Reinsurance Company of Bermuda Limited (MRB). A 100% quota share treaty with MRB covered all risks on the UK onshore wealth management portfolio (variable annuity guarantees and base contracts). MetLife Europe paid €4,452 million in total consideration for net reinsured liabilities of €4,107 million, structured through an initial reinsurance premium of €377 million with the remainder held in a funds-withheld arrangement — meaning the assets backing reinsured liabilities physically remained on MetLife Europe d.a.c.'s balance sheet while being economically allocated to MRB.

📉 Post-transfer de-risking. Interest on funds withheld amounted to €454 million (credit) in FY 2022, €222 million in FY 2023, and just €58 million in FY 2024, reflecting dramatic shrinkage following the Part VII transfer. Reinsurance recoverables on MetLife Europe d.a.c.'s Solvency II balance sheet fell from €2,818 million (FY 2023) to €370 million (FY 2024), a decrease of €2,448 million. Deposits from reinsurers collapsed from €2,604 million to €143 million at the group level. The Part VII transfer materially de-risked the Bermuda concentration.

⚖️ Residual risk and collateral. Prior to April 2024, MRB was an unrated affiliated entity with an indicative financial strength rating of MA1 assigned internally by MetLife Inc.'s Global Risk Management credit team, mitigated by a robust collateral arrangement. In the event of MRB default, MetLife Europe's exposure at default would have been the entire gross liability for variable annuity guarantees less the hedging portfolio value and policyholder assets held in funds withheld. Post-transfer, the remaining reinsurance with MRB is substantially smaller. MetLife Europe d.a.c. also utilises catastrophe reinsurance and single-exposure mortality/morbidity reinsurance above retention limits. MetLife Europe Insurance d.a.c. reinsures the majority of its Italian ILOE business and maintains arrangements with Alico US (outstanding intra-group balance of €9,505 thousand at FY 2024).

~*~

Investment portfolio

🏦 Conservative positioning. The group's investment portfolio contracted significantly following the Part VII transfer, which removed approximately €2,250 million in unit-linked assets from the balance sheet. The non-unit-linked portfolio is concentrated in fixed income (97% government and corporate bonds), reflecting the group's focus on cash-flow matching for protection liabilities.

📊 MetLife EU Holding Company Limited — Group investment composition (Solvency II, EUR mm), FY 2023–FY 2024

Asset class	FY 2024	FY 2023	Change
Government bonds	1,059	1,099	(40)
Corporate bonds	837	960	(123)
Collective investment undertakings	50	40	+10
Deposits & derivatives	11	7	+4
Non-UL investments	1,957	2,106	(149)
Unit-linked assets	1,583	3,833	(2,250)
Loans & mortgages	146	141	+5
Cash & equivalents	153	165	(12)
Total	3,839	6,245	(2,406)

🌐 Sovereign diversification. Government bonds are diversified across euro-area sovereigns plus Czech, Romanian, and Hungarian government paper for currency-matching against Central European guarantee business. Corporate bond holdings declined by €123 million, partly used to fund the 2024 dividend payment. The portfolio carries no investments in securitisations, negligible equity exposure, and minimal property holdings (€103 million of own-use property and equipment).

📈 Investment income. Operating investment income (non-unit-linked) improved as higher interest rates flowed through, rising from €66 million (FY 2022) to €81 million (FY 2024) at the group level. Unit-linked investment returns are inherently volatile and largely passed through to policyholders, generating €262 million in FY 2024 compared to a €622 million loss in FY 2022 during the equity market sell-off.

~*~

SCR risk profile

📋 Standard formula. The group employs the Solvency II Standard Formula for SCR calculation, with no internal model or partial internal model in use and no capital add-ons imposed by the CBI. The group applies the volatility adjustment to Euro-denominated liabilities in six branches (Cyprus, France, Italy, Portugal, Slovakia, Spain) and Euro liabilities from Bulgaria, approved by the CBI since 31 December 2020. The VA impact is modest — increasing own funds by €16 million and reducing the SCR by €1 million in FY 2024. No transitional measures or matching adjustment are applied.

📊 MetLife EU Holding Company Limited — Group SCR breakdown by risk module (EUR mm), FY 2022–FY 2024

Risk module	FY 2024	FY 2023	FY 2022
Life underwriting	503	471	457
Health underwriting	166	184	191
Non-life underwriting	13	11	9
Market risk	193	189	185
Counterparty default	73	46	55
Diversification	(267)	(253)	(256)
Basic SCR	681	648	641
Operational risk	73	71	68
LACDT	(64)	(75)	(79)
Other (credit institutions)	4	4	4
Total SCR	694	648	634

🛡️ Underwriting dominance. Underwriting risk accounts for 67% of the pre-diversification, pre-tax capital requirement (FY 2024), making this fundamentally an insurance risk business. Within underwriting, lapse risk is the single largest sub-module at €472 million, reflecting the mass-lapse stress on the profitable protection book, followed by mortality (€147 million), catastrophe (€145 million), and disability/morbidity (€104 million, up from €86 million after modelling refinements for UK Group Income Protection).

💱 Market risk composition. Market risk contributes 19% of the pre-diversification requirement, with equity risk (€84 million), currency risk (€75 million), and interest rate risk (€41 million) as the primary sub-components. The decline in interest rate risk SCR from €55 million to €41 million reflects lower absolute rates and the standard formula's rate-down shock mechanics. Currency risk increased as GBP exposure rose from the retained UK branch and USD strengthened.

~*~

Governance and regulatory environment

👩‍💼 Leadership. MetLife Europe d.a.c. is led by Nuria Garcia, who serves as Regional President for EMEA, Head of Global Sustainability, and CEO of both MetLife Europe d.a.c. and MetLife Europe Insurance d.a.c. Garcia was appointed on 1 January 2021, succeeding Dirk Ostijn, and brings over two decades of EMEA experience spanning distribution, operations, and finance, including prior roles as COO of MetLife Europe and 15 years at GE. Nicolas Hayter serves as Regional CFO for EMEA and has been a director of MetLife Europe d.a.c. since approximately 2009.

🏗️ Board composition. The MetLife Europe d.a.c. board includes a mix of executive and independent non-executive directors: Nuria Garcia (CEO), Nicolas Hayter (CFO), Maureen McQueen (executive director), and several Irish INEDs including Ruairí O'Flynn, Eilish Finan, Brenda Dunne (Fellow of the Society of Actuaries in Ireland, also INED at Irish Life), and Miriam Sweeney. Additional directors include Lyndon Oliver (also Regional President, Asia at MetLife Inc.) and Edward Palmer. The Board of MetLife EU Holding Company Limited has no standing committees; MetLife Europe d.a.c.'s board operates through Audit, Risk, Investment, and Nomination committees. Since March 2025, the CRO and Chief Compliance Officer serve across all three group entities, consolidating governance efficiency.

🔍 CBI supervisory priorities. The Central Bank of Ireland reorganised its insurance supervision in 2025 under a single Insurance Directorate led by Seana Cunningham. The CBI's 2025 priorities are directly relevant to MetLife Europe d.a.c. on several fronts. On corporate substance, the CBI has warned that business models presenting a risk of day-to-day control operating outside Ireland will be closely monitored and that intra-group support should not undermine robust governance, adequate substantive presence, and strategic direction at the local level. For MetLife, where strategic decisions flow from New York via Munich to Dublin, this represents an area of ongoing supervisory focus.

🇪🇺 Cross-border regulatory tightening. Approximately 70% of Irish (re)insurance gross premiums derive from over 70 countries, and MetLife Europe d.a.c., operating in 14+ European markets from Dublin, exemplifies this model. EIOPA's revised Solvency II Directive (effective January 2027) will give host supervisors new tools to assess the relevance of cross-border activities in their markets, potentially increasing regulatory friction for Irish-passported firms. EIOPA's 2023 Supervisory Statement on Third-Country Governance clarified that EU firms should not resemble empty-shell companies and is directly relevant to MetLife Europe d.a.c.'s retained UK branch. The Insurance Recovery and Resolution Directive (IRRD), published in January 2025, will further harmonise cross-border supervision when transposed by January 2027.

~*~

Peer comparison

📏 Scale differential. MetLife Europe d.a.c. is a solo entity with €1,270 million in premium and fee income — roughly one-tenth of NN Group's group GWP (€13,978 million) and one-thirtieth of CNP Assurances' premium income (€37,400 million). NN Group's Insurance Europe segment (covering CEE/Southern European markets similar to MetLife Europe's footprint, including the former MetLife Poland and Greece operations) is the most directly comparable benchmark.

📊 Solvency II ratio comparison — MetLife Europe, NN Group, CNP Assurances, FY 2022–FY 2024

Entity	FY 2022	FY 2023	FY 2024	Trend
MetLife Europe d.a.c. (solo)	198%	190%	161%	Declining (−37pp)
MetLife EU Holding (group)	208%	201%	172%	Declining (−36pp)
NN Group N.V. (group)	197%	197%	194%	Stable (−3pp)
CNP Assurances (group)	230%	253%	237%	Mixed (+7pp net)

📊 Solvency divergence. MetLife Europe's solo solvency ratio at 161% sits materially below both peer group benchmarks. NN Group's stable 194% reflects disciplined capital generation and a mature, diversified Dutch core. CNP Assurances' elevated 237% is partly structural, reflecting French profit-sharing reserve mechanics that inflate Solvency II own funds. MetLife Europe's ratio has fallen 37 percentage points over two years while NN Group's moved just 3 points.

📊 Operating performance comparison — MetLife Europe, NN Group Insurance Europe, CNP Assurances (ex-France Europe), FY 2024

Metric	MetLife Europe d.a.c.	NN Group Ins. Europe	CNP Assurances (ex-France)
Premium income (EUR mm)	1,270	—	~5,700
Operating result (EUR mm)	137	559	—
Operating result growth	+14%	+19%	—
Value of new business (EUR mm)	—	254	—
Premium growth	+9.1%	+6.0%	+5.1%

🏅 Growth versus scale. MetLife Europe's 9.1% premium growth outpaced both peer groups, though part of this reflects the composition of its retained portfolio (employee benefits rather than traditional savings). NN Group's Insurance Europe segment delivered a stronger absolute operating result (€559 million versus MetLife Europe's €137 million profit), reflecting the scale advantage of the integrated CEE platform which now includes the former MetLife Poland and Greece operations.

📊 Credit rating comparison — MetLife, NN Group, CNP Assurances (as of March 2025)

Agency	MetLife (MLIC)	NN Group	CNP Assurances
S&P IFSR	AA−	A+	— (issuer: A)
Moody's IFSR	Aa3	—	A1
Fitch IFSR	AA−	AA−	A+ (Neg outlook)
AM Best FSR	A+ (Superior)	—	—

🔐 Credit strength. MetLife benefits from the strongest credit quality among the three groups at the operating company level. MetLife Europe d.a.c. itself does not carry standalone ratings from any major agency — it relies implicitly on parental support from MetLife Inc.

~*~

Credit ratings

🏆 Five-year stability. MetLife Inc.'s credit profile has been remarkably stable throughout the review period, with no rating changes, upgrades, downgrades, or outlook revisions from any of the four major agencies between 2020 and 2025.

📊 MetLife Inc. — Current credit ratings (as of March 2025)

Agency	MLIC (IFSR)	MetLife Inc. (Senior debt)	Outlook
S&P	AA−	A−	Stable
Moody's	Aa3	A3	Stable
Fitch	AA−	A−	Stable
AM Best	A+ / ICR "aa−"	ICR "a−"	Stable

⭐ AM Best affirmation. AM Best's March 2025 affirmation cited strong balance sheet strength, strong operating performance, a very favourable business profile diversified by geography, business line, and distribution channel, and appropriate enterprise risk management. The rating agency flagged mortgage exposure as an area for ongoing monitoring. MetLife Europe d.a.c. benefits from implicit group support but carries no standalone agency ratings; the 2024 SFCR references an S&P financial strength rating of A+ in UK marketing disclosures. MetLife Global Benefits, Ltd. — an entity serving international/European markets — is explicitly rated A+ (Superior) / "aa−" (Superior) by AM Best as part of the Metropolitan Life Insurance Group.

~*~

New Frontier strategy

🎯 Strategic framework. MetLife Inc. unveiled its New Frontier five-year strategy at its 12 December 2024 Investor Day, succeeding the Next Horizon strategy (2019–2024) which exceeded all targets — 15.1% adjusted ROE (versus 12–14% target), $21 billion in free cash flow (versus ~$20 billion target), and approximately 90% total shareholder return.

📊 MetLife Inc. — New Frontier financial commitments versus Next Horizon achieved

Metric	New Frontier (2024–2029)	Next Horizon (achieved)
Adj EPS growth	Double-digit	~6%
Adj ROE	15–17%	15.1%
Direct expense ratio	11.3% (−100bps)	12.3%
Free cash flow (5-year cumul.)	$25bn+	$21bn

🌏 Growth priorities. The strategy rests on four pillars: extending US Group Benefits leadership, capitalising on the retirement platform (US, Japan, UK longevity reinsurance), accelerating MetLife Investment Management toward $1 trillion in AUM, and expanding in high-growth international markets — explicitly defined as Mexico, Brazil, India, and China, which represent 40% of global population and a $0.5 trillion life insurance market.

🐄 Europe as cash cow. EMEA's role is conspicuously modest, contributing just 4% of MetLife Inc.'s adjusted earnings and receiving no specific growth targets or strategic investment commitments at Investor Day. Forward guidance projects mid-to-high single-digit adjusted PFO growth for EMEA, unremarkable against Latin America's high-single-digit target or Asia's double-digit growth trajectory. MetLife Europe d.a.c. paid €193 million in dividends upstream in FY 2024 (up from €160 million in FY 2023), representing an effective dividend payout ratio of approximately 141% of Irish GAAP profit — a level only sustainable because the entity is drawing down accumulated surplus.

🏗️ UK longevity reinsurance. One strategic bright spot connects EMEA to MetLife Inc.'s broader ambitions: UK longevity reinsurance is cited as a growth area under the Retirement Investment Solutions segment (not EMEA). MetLife grew UK funded reinsurance balances to $26 billion from a standing start in 2020, targeting the £50 billion annual UK longevity de-risking market. This business sits in MetLife UK or RIS structures, not in MetLife Europe d.a.c.

💰 Capital return. MetLife returned approximately $21 billion to shareholders over 2020–2024, comprising ~$14.7 billion in buybacks and ~$7.6 billion in dividends. The common dividend grew at an 8.7% CAGR since 2011, reaching $2.155 per share for FY 2024. Holding company cash and liquid assets stood at $5.1 billion at year-end 2024, above the $3.0–$4.0 billion target buffer.

~*~

Technical provisions and the Part VII transfer

📑 Balance sheet transformation. The UK Part VII transfer radically altered MetLife Europe d.a.c.'s balance sheet composition without changing its fundamental economic substance. The transferred portfolio was a fully reinsured unit-linked book — gross liabilities were offset almost entirely by reinsurance recoverables from MRB. Removing both sides simultaneously had limited impact on net technical provisions but dramatically changed the gross balance sheet.

📊 MetLife EU Holding Company Limited — Technical provisions (Solvency II, EUR mm), FY 2022–FY 2024

Component	FY 2024	FY 2023	FY 2022
Best estimate — life	2,441	4,685	4,688
Risk margin — life	203	194	191
Best estimate — non-life	5	4	10
Risk margin — non-life	14	14	13
Gross technical provisions	2,663	4,897	4,902
Reinsurance recoverables	(378)	(2,828)	(3,016)
Net technical provisions	2,285	2,069	1,886

📐 Gross-to-net decomposition. Gross technical provisions fell by €2,234 million — almost entirely attributable to the Part VII transfer of the UK unit-linked portfolio. Simultaneously, reinsurance recoverables decreased by €2,450 million. Net technical provisions actually increased by €216 million (from €2,069 million to €2,285 million), demonstrating the organic growth of the retained protection book. Total group assets shrank from €9,415 million (FY 2023) to €4,589 million (FY 2024), and total liabilities from €8,111 million to €3,394 million. The excess of assets over liabilities decreased by €109 million (from €1,304 million to €1,195 million), representing the net capital outflow from dividends and the Part VII transfer minus operating profits.

~*~

Risk experience and emerging threats

🔄 Lapse experience. Lapse risk SCR is the single largest component at €472 million (FY 2024), but actual lapse experience was better than expected — particularly in Romania, where favourable persistency contributed positively to own funds. Assumption updates for Italy and Portugal previously reduced the lapse SCR in FY 2023.

🏥 Mortality and morbidity. Claims experience has been mixed. Positive claims experience in the UK and Italy contributed to own funds in FY 2024, but the disability/morbidity risk SCR increased from €86 million to €104 million following modelling refinements for UK Group Income Protection. The FY 2023 period saw higher claims in UK group business and Italian operations as a negative factor.

🤖 Emerging risk register. Items identified in the 2024 SFCR include AI proliferation (regulatory and operational implications), geopolitical risk (Ukraine, Middle East, potential US–EU tariffs), regulatory change (DORA effective January 2025, the EU AI Act, EIOPA's Individual Assessment Framework, and the Solvency II review), and climate risk. The CBI's designation as a market surveillance authority under the AI Act for life and health insurance pricing represents a novel regulatory vector.

~*~

Priority investigation findings

🔎 Why the group solvency ratio declined from 208% to 172%. The decline is predominantly a capital management outcome, not an adverse risk event. Approximately 70–80% of the decline is attributable to dividend payments upstream (cumulative ~€376 million in 2023–2024 from the holding company to its German parent) and the Part VII transfer of €246 million in net assets outside the group perimeter. The remaining 20–30% reflects SCR growth from business expansion (life underwriting SCR +€46 million) and reduced tax-absorption capacity (LACDT −€15 million). Operating profits and favourable experience provided partial offsets of approximately 10–15 percentage points. The ORSA concludes the group is adequately capitalised, and the ratio remains well above the 100% regulatory floor.

🏝️ Scale and nature of affiliated reinsurance with MetLife Bermuda. The MRB relationship has been substantially de-risked by the Part VII transfer. Prior to April 2024, the 100% quota share treaty on the UK wealth management portfolio generated reinsurance recoverables of €2,818 million, backed by a funds-withheld arrangement. Post-transfer, recoverables fell to €370 million. MRB is unrated but assigned an indicative MA1 by MetLife's internal credit team, with collateral arrangements mitigating loss-given-default risk. The residual concentration risk, while reduced, remains a factor for monitoring given MRB's affiliated status and the absence of an independent credit assessment.

🇮🇪 Sustainability of the Irish passporting model post-Brexit. The model is sustainable but faces incrementally tighter regulatory oversight. The CBI's 2025 priorities explicitly target business models where day-to-day control may operate outside Ireland. EIOPA's revised Solvency II Directive (effective 2027) will empower host supervisors to scrutinise cross-border activities more aggressively. The Part VII transfer was a direct response to UK third-country branch requirements, and the retained UK branch will continue to attract supervisory attention. Demonstrating genuine Irish corporate substance — board independence, local decision-making authority, adequate staffing — will be an ongoing compliance priority.

💼 Europe's role under New Frontier: growth platform or cash cow. Cash cow. EMEA contributes 4% of group adjusted earnings, received no specific growth investment commitments at Investor Day, and faces mid-to-high single-digit PFO growth guidance versus double-digit targets for Asia. The dividend payout ratio (141% of Irish GAAP profit in FY 2024) is mathematically unsustainable without either reducing dividends or growing profits faster. The EPIFP of €1,059 million provides a substantial embedded value buffer that can support continued capital extraction for several more years. The strategic interest in UK longevity reinsurance operates outside the MetLife Europe d.a.c. perimeter.

📊 Expense ratio comparison with peers. MetLife Europe d.a.c.'s operating expenses of €205 million on premium and fee income of €1,270 million imply an operating expense ratio of approximately 16.1%, excluding commission costs (€376 million in variable expenses including commission). Including all variable expenses, the total expense loading is approximately 55% of premium and fee income. MetLife Inc. targets a group-wide direct expense ratio reduction from 12.3% to 11.3% under New Frontier. The lack of standardised, segment-level expense ratio disclosure across all three peers limits the analytical value of this comparison.

~*~

Conclusion

🏢 Well-run platform with structural tensions. MetLife's European operations represent a mature, profitable insurance platform that performs its designated role within the MetLife Inc. group architecture: generating consistent cash flows for upstream distribution to shareholders. The business is well-diversified across protection, employee benefits, and (historically) wealth management products in 14+ European markets, with underwriting risk — not investment risk — as the dominant risk driver.

⚠️ Three tensions to monitor. First, the solvency trajectory creates a narrowing margin of safety: at 161% (solo) and 172% (group), the buffers are adequate but leave limited room for adverse scenarios while sustaining current dividend levels. If MetLife Inc. continues extracting ~€190 million annually while the business grows (increasing the SCR), the solvency ratio will continue compressing unless retained profits accelerate. Second, the regulatory environment is tightening for Irish-passported cross-border insurers, with the CBI's corporate substance expectations and EIOPA's host-supervisor empowerment under the revised Solvency II Directive increasing compliance costs over 2025–2027. Third, strategic ambiguity around Europe's role — the disposal of Poland and Greece, the UK portfolio restructuring, and the absence of EMEA growth targets at Investor Day all point toward optimisation rather than expansion.

✅ Credit quality remains strong. Five-year rating stability across all four agencies, a robust parental guarantee framework from MetLife Inc. (holding $5.1 billion in holding company liquidity), an EPIFP buffer of over €1 billion, and a well-managed investment portfolio with virtually no exposure to equities or alternatives collectively support the conclusion that MetLife Europe is a low-to-moderate risk counterparty with sufficient capital for its current risk profile — provided the pace of capital extraction moderates as solvency buffers narrow.

~*~